Sign Up
Stories
Advancements in Medical Research
Share
Advancements in Cancer Treatment and Mar...
Positive Data for Axatilimab in GVHD Tre...
Advancements in Medical Trials
IVIg Offers Hope for 20-Year Remission i...
Mesoblast's FDA Progress and Approvals
Overview
API
Incyte and Syndax present positive data for axatilimab in treating chronic GvHD, while GeNeuro recommends continuing a study on temelimab for post-COVID-19 syndrome.
Ask a question
How do advancements in medical research contribute to the development of new treatments and therapies for various conditions?
How might the positive data for axatilimab impact the treatment of chronic GvHD?
What potential implications does the continued study on temelimab have for post-COVID-19 syndrome patients?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Sep 2023
Oct 2023
Nov 2023
Dec 2023
Coverage